人糖尿病肾小球与小管间质转录组新见解
该研究对19例糖尿病肾病患者和20例活体肾供者的配对肾小球与小管间质组织进行RNA测序,发现两部位转录组明显分离,分别鉴定出1550和4530个差异表达基因,富集于炎症、细胞外基质组织、免疫和凋亡通路,并与肾功能相关。
要点
- 肾小球以炎症和细胞外基质组织通路激活为主。
- 小管间质以免疫和凋亡通路激活为主。
- 尿NGAL和KIM-1在糖尿病肾病患者中升高,与对应mRNA表达增加一致。
核心结论
- 糖尿病肾病患者肾小球和小管间质均发生显著的疾病特异性转录组改变。
- 高通量转录组学有助于解析糖尿病肾病通路和治疗靶点。
研究设计与样本
- 对19例糖尿病肾病患者(15男,中位年龄61岁,CKD 1-4期)和20例活体肾供者(12男,中位年龄56岁)的配对、显微切割肾小球和小管间质组织进行RNA测序。
主要发现
- 主成分分析显示肾小球和小管间质转录组明显分离。
- 差异表达分析分别鉴定出1550和4530个差异表达基因(校正P<0.01)。
- 基因本体和KEGG富集分析提示肾小球中炎症和细胞外基质组织通路激活,小管间质中免疫和凋亡通路激活。
- 加权基因共表达网络分析发现特定基因模块与肾功能相关。
- 糖尿病肾病患者小管间质中LCN和HAVCR1的mRNA表达增加,尿中NGAL和KIM-1浓度升高。
临床怎么用
- 可关注肾小球炎症和ECM组织通路以及小管间质免疫和凋亡通路作为潜在干预靶点。
- 尿NGAL和KIM-1可能反映小管间质损伤的转录组改变。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Diabetic nephropathy (DN) is the most common cause of end-stage renal disease, affecting ∼30% of the rapidly growing diabetic population, and strongly associated with cardiovascular risk. Despite this, the molecular mechanisms of disease remain unknown. METHODS: RNA sequencing (RNAseq) was performed on paired, micro-dissected glomerular and tubulointerstitial tissue from patients diagnosed with DN [n = 19, 15 males, median (range) age: 61 (30-85) years, chronic kidney disease stages 1-4] and living kidney donors [n = 20, 12 males, median (range) age: 56 (30-70) years]. RESULTS: Principal component analysis showed a clear separation between glomeruli and tubulointerstitium transcriptomes. Differential expression analysis identified 1550 and 4530 differentially expressed genes, respectively (adjusted P < 0.01). Gene ontology and Kyoto Encyclopedia of Genes and Genomes enrichment analyses highlighted activation of inflammation and extracellular matrix (ECM) organization pathways in glomeruli, and immune and apoptosis pathways in tubulointerstitium of DN patients. Specific gene modules were associated with renal function in weighted gene co-expression network analysis. Increased messengerRNA (mRNA) expression of renal damage markers lipocalin 2 (LCN) and hepatitis A virus cellular receptor1 (HAVCR1) in the tubulointerstitial fraction was observed alongside higher urinary concentrations of the corresponding proteins neutrophil gelatinase-associated lipocalin (NGAL) and kidney injury molecule-1 (KIM-1) in DN patients. CONCLUSIONS: Here we present the first RNAseq experiment performed on paired glomerular and tubulointerstitial samples from DN patients. We show that prominent disease-specific changes occur in both compartments, including relevant cellular processes such as reorganization of ECM and inflammation (glomeruli) as well as apoptosis (tubulointerstitium). The results emphasize the potential of utilizing high-throughput transcriptomics to decipher disease pathways and treatment targets in this high-risk patient population.
引用
- Levin A, Reznichenko A, Witasp A, et al. Novel insights into the disease transcriptome of human diabetic glomeruli and tubulointerstitium. Nephrol Dial Transplant. 2020. PMID: 32853351. doi:10.1093/ndt/gfaa121
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。